Scout | Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

This grant opportunity supports early stage testing of new drug or device-based treatments for mental disorders. It emphasizes an experimental approach that not only evaluates the treatment's effects but also explores the underlying mechanisms of the disorder or response. The goal is to test treatments with novel mechanisms and understand how they work, ensuring the treatment causes specific d…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: March 2, 2021

Open for Submission: March 2, 2021

Submission Deadline: October 15, 2024

Application Window Closes: October 15, 2024

Keywords

Mental Disorders

Early Stage Testing

Pharmacologic Interventions

Device-based Interventions

Clinical Trial

Experimental Therapeutics

Therapeutic Interventions

Mechanisms of Action

Neurophysiological Effect

Behavioral Effect

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers